Article

Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors

Department of Chemistry, Altai State Technical University, Barnaul 656038, Russia.
European Journal of Medicinal Chemistry (Impact Factor: 3.45). 11/2010; 45(11):5406-19. DOI: 10.1016/j.ejmech.2010.09.001
Source: PubMed

ABSTRACT

N-formyl peptide receptors (FPRs) are important in host defense. Because of the potential for FPRs as therapeutic targets, recent efforts have focused on identification of non-peptide agonists for two FPR subtypes, FPR1 and FPR2. Given that a number of specific small-molecule agonists have recently been identified, we hypothesized that computational structure-activity relationship (SAR) analysis of these molecules could provide new information regarding molecular features required for activity. We used a training set of 71 compounds, including 10 FPR1-specific agonists, 36 FPR2-specific agonists, and 25 non-active analogs. A sequence of (1) one-way analysis of variance selection, (2) cluster analysis, (3) linear discriminant analysis, and (4) classification tree analysis led to the derivation of SAR rules with high (95.8%) accuracy for correct classification of compounds. These SAR rules revealed key features distinguishing FPR1 versus FPR2 agonists. To verify predictive ability, we evaluated a test set of 17 additional FPR agonists, and found that the majority of these agonists (>94%) were classified correctly as agonists. This study represents the first successful application of classification tree methodology based on atom pairs to SAR analysis of FPR agonists. Importantly, these SAR rules represent a relatively simple classification approach for virtual screening of FPR1/FPR2 agonists.

Download full-text

Full-text

Available from: Mark T Quinn, Jun 20, 2014
  • Source
    • "On the other hand, when we performed molecular docking of CsH into the structures of both Val101 and Leu101 variants, we found that the docking pose of CsH overlapped well with that of fMLF for both FPR1 variants. Closer inspection, however, showed that CsH binds the Val101 FPR1 variant in quite a different pose compared to the Leu101 variant and is located closer to channel C of the protein surface (Fig. 2; orthosteric FPR1 binding site regions are designated as in our previous publication [37]). Although CsH docking with either the Leu101 or Val101 FPR1 variant formed H-bonds with Arg205 and Tyr257, CsH also formed an H-bond with Cys98 of the Val101 variant, which is located in the vicinity of channel C. Possibly, this H-bond constrains CsH in a relatively unfavorable position that reduces its antagonist activity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca(2+) mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.
    Full-text · Article · Sep 2015 · International immunopharmacology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The CORAL software (http:/www.insilico.eu/CORAL) has been examined as a tool of modeling of the angiotensin-converting enzyme-inhibitor activity of 54 tri-peptides. Three versions of the models were examined: (i) models based on the graph of atomic orbitals (GAO); (ii) models based on the simplified molecular input-line entry systems (SMILES); and (iii) hybrid models based on both GAO and SMILES. The hybrid models have provided the best prediction. The robustness of the approach has been checked with four random splits into training set and test set.
    Full-text · Article · Dec 2012 · Structural Chemistry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) expressed on a variety of cell types. These receptors play an important role in the regulation of inflammatory reactions and sensing cellular damage. They have also been implicated in the pathogenesis of various diseases, including neurodegenerative diseases, cataract formation, and atherogenesis. Thus, FPR ligands, both agonists and antagonists, may represent novel therapeutics for modulating host defense and innate immunity. A variety of molecules have been identified as receptor subtype-selective and mixed FPR agonists with potential therapeutic value during last decade. This review describes our efforts along with recent advances in the identification, optimization, biological evaluation, and structure-activity relationship (SAR) analysis of small molecule non-peptide FPR agonists and antagonists, including chiral molecules. Questions regarding the interaction at the molecular level of benzimidazoles, pyrazolones, pyridazin-3(2H)-ones, N-phenylureas and other derivatives with FPR1 and FPR2 are discussed. Application of computational models for virtual screening and design of FPR ligands is also considered.
    Full-text · Article · Dec 2013 · Current Medicinal Chemistry
Show more